Several biomarkers such as NGAL, KIM-1, L-FABP, or IL-18 are able to exclude the ATN-AKI with great accuracy; however, for some of them the exact specificity and sensitivity remain unclear and emphasize the need for further studies on different populations. Here, HAVCR1 is linked to acute kidney injury.